Repaglinide is a diabetic drug, and is a non sulfonylurea type insulin releasing agent. Clinically, it is mainly used for patients with type 2 diabetes mellitus (non-insulin-dependent) who have diet control, weight reduction and exercise control which can not effectively control hyperglycemia.